Align Technology Inc (ALGN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Align Technology Inc (ALGN) has a cash flow conversion efficiency ratio of 0.036x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($151.04 Million) by net assets ($4.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market value of Align Technology Inc for the company's overall valuation and market capitalisation.
Align Technology Inc - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Align Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Align Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Align Technology Inc ranked by their cash flow conversion efficiency. Explore ALGN cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sunoco LP
NYSE:SUN
|
0.072x |
|
Advanced Fiber Resources Zhuhai Ltd
SHE:300620
|
0.073x |
|
Max Healthcare Institute Limited
NSE:MAXHEALTH
|
0.076x |
|
Jiangxi Ganfeng Lithium Co Ltd
SHE:002460
|
-0.016x |
|
HubSpot Inc
NYSE:HUBS
|
0.254x |
|
BIM Birlesik Magazalar AS
IS:BIMAS
|
0.125x |
|
RAIFFEIS. UNSPON.ADR/1/4
F:RAW0
|
0.025x |
|
Alcoa Corp
NYSE:AA
|
0.040x |
Annual Cash Flow Conversion Efficiency for Align Technology Inc (1999–2025)
The table below shows the annual cash flow conversion efficiency of Align Technology Inc from 1999 to 2025. View ALGN stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.05 Billion | $593.22 Million | 0.147x | -23.56% |
| 2024-12-31 | $3.85 Billion | $738.23 Million | 0.192x | -11.45% |
| 2023-12-31 | $3.63 Billion | $785.78 Million | 0.216x | +37.05% |
| 2022-12-31 | $3.60 Billion | $568.73 Million | 0.158x | -51.21% |
| 2021-12-31 | $3.62 Billion | $1.17 Billion | 0.324x | +58.07% |
| 2020-12-31 | $3.23 Billion | $662.17 Million | 0.205x | -63.11% |
| 2019-12-31 | $1.35 Billion | $747.27 Million | 0.555x | +25.39% |
| 2018-12-31 | $1.25 Billion | $554.68 Million | 0.443x | +16.13% |
| 2017-12-31 | $1.15 Billion | $438.54 Million | 0.381x | +53.22% |
| 2016-12-31 | $995.39 Million | $247.65 Million | 0.249x | -11.36% |
| 2015-12-31 | $847.93 Million | $238.00 Million | 0.281x | -6.88% |
| 2014-12-31 | $752.77 Million | $226.90 Million | 0.301x | +2.75% |
| 2013-12-31 | $633.97 Million | $185.98 Million | 0.293x | +27.47% |
| 2012-12-31 | $581.32 Million | $133.78 Million | 0.230x | -13.43% |
| 2011-12-31 | $490.78 Million | $130.47 Million | 0.266x | -22.47% |
| 2010-12-31 | $377.75 Million | $129.53 Million | 0.343x | +26.24% |
| 2009-12-31 | $273.04 Million | $74.17 Million | 0.272x | +49.35% |
| 2008-12-31 | $218.54 Million | $39.75 Million | 0.182x | -44.47% |
| 2007-12-31 | $161.15 Million | $52.78 Million | 0.327x | +295.04% |
| 2006-12-31 | $83.56 Million | $-14.03 Million | -0.168x | -197.52% |
| 2005-12-31 | $93.44 Million | $16.09 Million | 0.172x | -39.90% |
| 2004-12-31 | $85.74 Million | $24.56 Million | 0.286x | +48.83% |
| 2003-12-31 | $62.98 Million | $12.12 Million | 0.192x | +133.65% |
| 2002-12-31 | $70.62 Million | $-40.40 Million | -0.572x | +26.96% |
| 2001-12-31 | $99.40 Million | $-77.86 Million | -0.783x | -212.79% |
| 2000-12-31 | $-84.67 Million | $-58.80 Million | 0.694x | +15.89% |
| 1999-12-31 | $-19.41 Million | $-11.63 Million | 0.599x | -- |
About Align Technology Inc
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisali… Read more